Brief: ContraFect Prices About $10 Mln Public Offering Of Common Stock And Concurrent $3 Mln Private Placement Of Common Stock To Pfizer
Dec 10 (Reuters) - ContraFect Corp CFRX.O :
* CONTRAFECT CORPORATION PRICES APPROXIMATELY $10 MILLION
PUBLIC
OFFERING OF COMMON STOCK AND CONCURRENT $3 MILLION PRIVATE
PLACEMENT OF COMMON STOCK TO PFIZER
* CONTRAFECT CORP - PRICING OF ITS UNDERWRITTEN PUBLIC
OFFERING OF
37.2 MILLION SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING
PRICE OF $0.27 PER SHARE
* CONTRAFECT CORP - ALSO ANNOUNCED THAT PFIZER INC. HAS
AGREED TO
PURCHASE 11.1 MILLION SHARES OF CO'S COMMON STOCK PURSUANT TO A
STOCK PURCHASE AGREEMENT
Source text for Eikon: ID:nGNX5ZvSfG
Further company coverage: CFRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CONTRAFECT
See all newsBrief: Contrafect Corp - On Nov 7, Co Received Delisting Notification From Nasdaq Hearings Advisor Stating That Panel Determined To Delist Co's Common Stock
Brief: ContraFect Says Selling Securityholder May Offer And Selling Up To 7 Mln Shares In Aggregate Of Common Stock
Brief: Contrafect Announces FDA Clearance Of CF-370 IND Application To Proceed With Phase 1 Clinical Study
Brief: Contrafect Corp Says On Sept 21, Notified By Nasdaq, That Co Not In Compliance With The Minimum Bid Price Requirement
Brief: Contrafect Announces Submission Of Ind Application To The FDA For Its Development Candidate Cf-370